PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Graduate Program in Pharmaceutical Nanotechnology, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil; Dispersed Systems Laboratory (LaSiD), Pharmacy Department, UFRN, Natal, Brazil.\', \'Dispersed Systems Laboratory (LaSiD), Pharmacy Department, UFRN, Natal, Brazil.\', \'Graduate Program in Health Sciences, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil; Dispersed Systems Laboratory (LaSiD), Pharmacy Department, UFRN, Natal, Brazil.\', \'Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.\', \'Graduate Program in Pharmaceutical Nanotechnology, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil; Graduate Program in Health Sciences, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil; Dispersed Systems Laboratory (LaSiD), Pharmacy Department, UFRN, Natal, Brazil. Electronic address: socrates@ufrnet.br.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0753-3322(21)00363-210.1016/j.biopha.2021.111578
?:doi
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 33848774
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33848774>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33848774>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all